HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc O Maybauer Selected Research

Smoke Inhalation Injury

1/2018Extracorporeal membrane oxygenation in severe respiratory failure resulting from burns and smoke inhalation injury.
5/2013Extracorporeal membrane oxygenation in burn and smoke inhalation injury.
8/2011The peroxynitrite catalyst WW-85 improves microcirculation in ovine smoke inhalation injury and septic shock.
2/2011Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury.
11/2010A novel antibiotic based long-term model of ovine smoke inhalation injury and septic shock.
3/2010Management of acute smoke inhalation injury.
1/2010Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock.
6/2009Pathophysiology, management and treatment of smoke inhalation injury.
4/2008Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep.
7/2007Ceftazidime improves hemodynamics and oxygenation in ovine smoke inhalation injury and septic shock.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc O Maybauer Research Topics

Disease

15Smoke Inhalation Injury
01/2018 - 02/2005
14Burns
01/2018 - 12/2005
14Sepsis (Septicemia)
01/2015 - 09/2005
13Septic Shock (Toxic Shock Syndrome)
01/2017 - 09/2005
11Acute Lung Injury
02/2012 - 02/2005
6Shock
12/2021 - 06/2006
6Respiratory Insufficiency (Respiratory Failure)
12/2021 - 05/2013
6Airway Obstruction (Choking)
02/2012 - 05/2006
4Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2022 - 04/2008
4Hemorrhage
04/2022 - 09/2006
4Wounds and Injuries (Trauma)
04/2012 - 03/2010
4Lung Injury
05/2011 - 07/2007
3Pulmonary Edema
05/2011 - 04/2008
2Critical Illness (Critically Ill)
07/2022 - 01/2014
2Thrombocytopenia (Thrombopenia)
04/2022 - 06/2017
2Infections
12/2021 - 02/2016
2Heart Arrest (Cardiac Arrest)
10/2020 - 09/2015
2Aortic Dissection
10/2020 - 12/2019
2Heart Failure
12/2019 - 06/2017
2Chronic Pain
08/2019 - 07/2017
2Neoplasms (Cancer)
10/2018 - 12/2008
2Pneumonia (Pneumonitis)
07/2014 - 05/2006
2Edema (Dropsy)
09/2006 - 02/2005
1Anaphylaxis (Anaphylactic Shock)
07/2022
1COVID-19
04/2022
1Hypoxia (Hypoxemia)
04/2022
1Hemolysis
12/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2021
1Pulmonary Embolism
10/2020
1Myasthenia Gravis
04/2020
1Cardiogenic Shock
12/2019
1Congenital Heart Defects (Congenital Heart Defect)
10/2017
1Acute Kidney Injury (Acute Renal Failure)
10/2017
1Postoperative Nausea and Vomiting (PONV)
07/2017
1Traumatic Brain Injuries (Traumatic Brain Injury)
04/2015
1Brain Death (Brain Dead)
01/2014
1Transfusion-Related Acute Lung Injury
01/2014
1Hyperglycemia
06/2012
1Insulin Resistance
06/2012
1Dyslipidemias (Dyslipidemia)
06/2012
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2012

Drug/Important Bio-Agent (IBA)

15SmokeIBA
01/2014 - 12/2005
5Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2018 - 05/2006
53-nitrotyrosineIBA
02/2012 - 05/2006
5Protein CIBA
02/2012 - 09/2006
5salicylhydroxamic acid (SHAM)IBA
08/2011 - 05/2006
4Vasopressins (Vasopressin)IBA
01/2017 - 02/2009
4Arginine Vasopressin (Argipressin)IBA
07/2014 - 09/2010
4drotrecogin alfa activated (Xigris)FDA Link
02/2012 - 09/2006
3CatecholaminesIBA
06/2012 - 02/2009
3Peroxynitrous Acid (Peroxynitrite)IBA
08/2011 - 05/2006
3Oxygen (Dioxygen)IBA
12/2009 - 02/2005
3NitrogenIBA
12/2009 - 07/2007
2Heparin (Liquaemin)FDA LinkGeneric
04/2022 - 06/2017
2Analgesics (Analgesic Drugs)IBA
07/2017 - 06/2013
2Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
07/2014 - 05/2011
2Malondialdehyde (Propanedial)IBA
02/2012 - 02/2011
2Ceftazidime (Fortum)FDA LinkGeneric
02/2012 - 07/2007
2Peroxidase (Myeloperoxidase)IBA
02/2012 - 02/2011
2Superoxides (Superoxide)IBA
02/2011 - 02/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2009 - 01/2009
2Superoxide DismutaseIBA
02/2006 - 02/2005
1AnticoagulantsIBA
04/2022
1ThrombinFDA Link
04/2022
1Tissue Plasminogen Activator (Alteplase)FDA Link
10/2020
1KetamineFDA LinkGeneric
05/2019
1Anesthetics (Anesthetic Agents)IBA
07/2017
1AntithrombinsIBA
06/2017
1bivalirudin (Angiomax)FDA Link
06/2017
1Neuromuscular Blocking AgentsIBA
04/2015
1esmolol (Brevibloc)FDA LinkGeneric
01/2015
1Hormones (Hormone)IBA
07/2014
1Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)- vasopressinIBA
07/2014
1EndotoxinsIBA
01/2014
1DexmedetomidineFDA Link
06/2013
1Hypnotics and Sedatives (Sedatives)IBA
06/2013
1Glucose (Dextrose)FDA LinkGeneric
06/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2012
1Insulin (Novolin)FDA Link
06/2012
1PPAR alphaIBA
06/2012
1Fenofibrate (CiL)FDA LinkGeneric
06/2012
1Hypoglycemic Agents (Hypoglycemics)IBA
06/2012
1BenzodiazepinesIBA
01/2012

Therapy/Procedure

12Extracorporeal Membrane Oxygenation
07/2022 - 05/2013
5Therapeutics
01/2018 - 12/2008
4Resuscitation
10/2020 - 06/2006
3Analgesia
08/2019 - 07/2017
2Anesthesia
07/2022 - 05/2011
2Cannula
04/2022 - 12/2021
2Acupuncture Therapy
08/2019 - 07/2017
2Critical Care (Surgical Intensive Care)
01/2014 - 11/2010
1Oxygenators
12/2021
1Cardiopulmonary Resuscitation (CPR)
10/2020
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2020
1Cardiopulmonary Bypass (Heart-Lung Bypass)
10/2018
1Renal Replacement Therapy (Therapies, Renal Replacement)
10/2017
1Craniotomy
07/2017
1Artificial Heart (Artificial Hearts)
01/2014
1Thoracostomy
04/2012
1Length of Stay
07/2011